NEW YORK--(BUSINESS WIRE)--
Pfizer Inc. invites investors and the general public to listen to a
webcast of a discussion with Chris Boshoff, senior vice president and
head, Immuno-Oncology, Early Development and Translational Oncology, at
the Evercore ISI HealthConX Conference on Wednesday, November 28, 2018
at 8:45 a.m. EST.
To listen to the webcast, visit our web site at www.pfizer.com/investors.
Information on accessing and pre-registering for the webcast will be
available at www.pfizer.com/investors
beginning today.
Visitors will be able to listen to an archived copy of the webcast at www.pfizer.com/investors.
Disclosure Notice: The webcast may include forward-looking
statements about, among other things, our anticipated future operating
and financial performance, business plans and prospects, in-line
products and product candidates, strategic reviews, capital allocation,
business-development plans, the benefits expected from our business
development transactions and plans relating to share repurchases and
dividends that are subject to substantial risks and uncertainties that
could cause actual results to differ materially from those expressed or
implied by such statements. A description of these risks and
uncertainties can be found in Pfizer’s Annual Report on Form 10-K for
the fiscal year ended December 31, 2017 and in its subsequent reports on
Form 10-Q, including in the sections thereof captioned “Risk Factors”
and “Forward-Looking Information and Factors That May Affect Future
Results”, as well as in its subsequent reports on Form 8-K, all of which
are filed with the U.S. Securities and Exchange Commission and available
at
www.sec.gov
and
www.pfizer.com
.
The forward-looking statements in the webcast speak only as of the
original date of the webcast. Pfizer assumes no obligation to update
forward-looking statements contained in the webcast as the result of new
information or future events or developments.
View source version on businesswire.com:
https://www.businesswire.com/news/home/20181121005027/en/
Media:
Joan Campion
(212) 733-2798
Investor:
Ryan
Crowe
(212) 733-8160
Source: Pfizer Inc.